Alkermes (ALKS) EBT Margin (2010 - 2026)

Alkermes' (ALKS) quarterly EBT Margin came in at 15.76% in Q1 2026, down 2408.0% year-on-year from 0.68% in Q1 2025, and down 200.38% on a QoQ basis from 15.7% in Q4 2025.

Alkermes (ALKS) EBT Margin (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of EBT Margin data on file, last reported at 15.76% in Q1 2026.

  • On a quarterly basis, EBT Margin fell 2408.0% year-over-year to 15.76% in Q1 2026; TTM through Mar 2026 was 13.06%, a 1484.0% decrease from a year earlier, with the FY2025 full-year figure at 19.75%, down 874.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 15.76%, down from 15.7% in the prior quarter.
  • Over the last five years, EBT Margin for ALKS reached as high as 45.65% in Q2 2023 and fell as low as 2105.25% in Q3 2022.
  • Historically, EBT Margin has averaged 168.79% across 5 years, with a median of 15.7% in 2025.
  • Across the five-year window, EBT Margin sank 209623 bps in 2022 and jumped 212959 bps in 2023, its largest moves.
  • Year by year, EBT Margin stood at 37.58% in 2022, then sank by 59 bps to 15.45% in 2023, then soared by 156 bps to 39.51% in 2024, then sank by 60 bps to 15.7% in 2025, then sank by 200 bps to 15.76% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 15.76% in Q1 2026, 15.7% in Q4 2025, and 25.56% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn -15.76%

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.76%
Dec 31, 2025 15.70%
Sep 30, 2025 25.56%
Jun 30, 2025 26.84%
Mar 31, 2025 8.32%
Dec 31, 2024 39.51%
Sep 30, 2024 29.15%
Jun 30, 2024 29.24%
Mar 31, 2024 13.39%
Dec 31, 2023 15.45%
Sep 30, 2023 24.34%
Jun 30, 2023 45.65%
Mar 31, 2023 -3.94%
Dec 31, 2022 37.58%
Sep 30, 2022 -2,105.25%
Jun 30, 2022 -1,039.06%
Mar 31, 2022 -16.15%
Dec 31, 2021 39.22%
Sep 30, 2021 -9.02%
Jun 30, 2021 1.86%